Integrated Diagnostics this week said it has launched a new operating division called InDi Imaging to commercialize PET imaging probes based on its protein catalyzed capture agent, or PCC, technology.

The company announced that it has appointed Norman Hardman president of the new division and appointed University of California, Los Angeles professor Michael Phelps, the inventor of PET, to the division as an advisor. It also said that it planned to start the first human studies of the PCC-based PET imaging reagents over the next 12 to 18 months.